Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

AU market earnings: Arcadium faces soft demand as neuron pharmaceuticals reaps royalty rewards

Arcadium reports a revenue dip to $255 million due to soft lithium demand, while Neuron Pharmaceuticals enjoys a royalty boost, signaling mixed market conditions and strategic adaptations in the face of global economic challenges.

Video poster image

[AI generated]

This video was created on 7 August for IG audiences by ausbiz.

Arcadium and Neuron tackle market challenges head-on

In the recent financial updates, Arcadium Lithium reported second-quarter revenue of $255 million, noting weak market sentiment and steady long-term demand for lithium, influenced by decreased demand for spodumene in China. The company is emphasizing efficient, high-quality operations, projecting a full-year capital expenditure of between $550 million and $700 million.

Meanwhile, Neuron Pharmaceuticals reported a royalty income of $13 million from Acadia Pharmaceuticals, with anticipated total royalties for 2024 ranging between $55 million and $61 million.


The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Speculate on commodities

Trade commodity futures, as well as 27 commodity markets with no fixed expiries.

  • Wide range of popular and niche metals, energies and softs
  • Spreads from 0.3 pts on Spot Gold, 2 pts on Spot Silver and 2.8 pts on Oil
  • View continuous charting, backdated for up to five years

Put learning into action

Try out what you’ve learned in this commodities strategy article risk-free in your demo account.

Ready to trade commodities?

Put the lessons in this article to use in a live account – upgrading is quick and easy.

  • Deal on our wide range of major and niche commodities
  • Protect your capital with risk management tools
  • Get some of the best spreads on the market – trade Spot Gold from 0.3 points

Inspired to trade?

Put what you’ve learned in this article into practice. Log in to your account now.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.